| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 24% | $18.5M | 10.3M | BVF PARTNERS L P/IL | 20 Nov 2025 | |||
| ARK Investment Management LLC | 4.7% | $2.2M | 2M | ARK Investment Management LLC | 31 Dec 2024 | |||
| MPM BioVentures 2014, L.P. | 4.6% | -10% | $2.14M | -$229K | 1.94M | -9.69% | ANSBERT GADICKE | 31 Jan 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 27.3M | $48M | -$586K | $1.76 | 44 |
| 2025 Q2 | 27.8M | $38.6M | -$1.38M | $1.39 | 49 |
| 2025 Q1 | 29.5M | $29.1M | -$1.27M | $0.99 | 49 |
| 2024 Q4 | 30.6M | $40.1M | -$3.25M | $1.31 | 53 |
| 2024 Q3 | 32.4M | $111M | -$4.68M | $3.44 | 56 |
| 2024 Q2 | 33.8M | $112M | -$7.68M | $3.30 | 60 |
| 2024 Q1 | 35.5M | $167M | -$6.37M | $4.71 | 70 |
| 2023 Q4 | 36.5M | $267M | +$7.11M | $7.30 | 69 |
| 2023 Q3 | 36.3M | $438M | +$5.86M | $12.08 | 75 |
| 2023 Q2 | 35.8M | $379M | +$27.7M | $10.58 | 77 |
| 2023 Q1 | 33.2M | $327M | -$3.87M | $9.84 | 77 |
| 2022 Q4 | 33.4M | $492M | +$9.27M | $14.71 | 81 |
| 2022 Q3 | 32.8M | $398M | -$27.7M | $12.13 | 68 |
| 2022 Q2 | 33.2M | $452M | +$10.1M | $13.99 | 71 |
| 2022 Q1 | 32.6M | $464M | -$16M | $14.24 | 61 |
| 2021 Q4 | 32.7M | $689M | +$73.9M | $21.09 | 65 |
| 2021 Q3 | 27M | $708M | +$8.75M | $26.24 | 66 |
| 2021 Q2 | 26.5M | $828M | +$17.3M | $31.18 | 61 |
| 2021 Q1 | 26M | $798M | +$23.2M | $30.69 | 64 |
| 2020 Q4 | 27.1M | $931M | +$31.4M | $34.30 | 61 |
| 2020 Q3 | 23.9M | $735M | +$25.9M | $30.77 | 37 |
| 2020 Q2 | 22.5M | $698M | +$698M | $31.02 | 47 |
| 2020 Q1 | 100 | $3K | $30.00 | 1 | |
| 2019 Q4 | 100 | $3K | $30.00 | 1 | |
| 2019 Q3 | 100 | $3K | $30.00 | 1 | |
| 2019 Q2 | 100 | $3K | $30.00 | 1 | |
| 2019 Q1 | 100 | $3K | $30.00 | 1 |